A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.

Clinical trial NCT00207701 · COMPLETED

Trial details

NCT number: NCT00207701
Sponsor: Centocor, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ankylosing Spondylitis

Start date: 2002-09-01
Enrollment: 279

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.